期刊文献+

良好的HLA配型可改善PRA高敏受者的移植效果 被引量:2

Good HLA matching can improved the transplant results on the PRA hypersensitivity recipient
下载PDF
导出
摘要 报告5例淋巴细胞群体反应抗体(PRA)为48%~76%,采用理想的HLA配型,供受者间HLA-A、B、DR位点在3~5个抗原相合情况下进行移植,术后3例发生急性排斥反应,经用甲基强的松龙及OKT3冲击治疗后排斥逆转。5例全部成功,术后均获得随访,人/肾存活9个月~2年4例,3年半1例。讨论了PRA高敏感对移植物的影响,良好的HLA配型对移植效果的影响。 Five patients with PRA positive rat reached 48~76% had accepted successful kidney transplanta-tion in our department, under good HLA matching that doners and recipients had 3~5 uniform situs onHLA-A,B,DR site. 3 cases had accured acute rejection after operation,but recovered by using methylpred-nisolone and OKT_3. They all followed up,the patient/kidney has survived for 9 months to 2 years in 4 cas-es. 3. 5 years in 1 case. In this report,we will discuss the influence of hypersensitivity of PRA on the graftand the improvement of transplant result by HLA matching on these patients.
出处 《第一军医大学学报》 CSCD 1997年第4期264-265,共2页 Journal of First Military Medical University
关键词 肾移植术 人类白细胞抗原 群体反应 抗体 kidney transplantation PRA HLA
  • 相关文献

参考文献2

  • 1于立新,中华泌尿外科杂志,1996年,11卷,663页
  • 2谭建明,国外医学泌尿系统分册,1995年,15卷,23页

同被引文献20

  • 1陈光耀,姚许平,陈跃英.环孢素A和他克莫司在高危肾移植患者中的应用比较[J].中华器官移植杂志,2005,26(2):111-112. 被引量:6
  • 2肖露露,肖巧珍,张仕光,吴培根,纪玉莲.群体反应性抗体(PRA)检测——附180例报告[J].中国免疫学杂志,1993,9(4):249-250. 被引量:11
  • 3杨蕾,刘永锋,张佳林,刘树荣,吴刚,孟一曼.肾移植术后患者趋化因子受体多态性的测定[J].中华外科杂志,2006,44(14):971-972. 被引量:1
  • 4High Risk Renal Transplant Consensus Group.Defining hish risk in adult kidney transplantation.Prog Transplant,2009,19:252-258.
  • 5Kliem V,Burg M,Haller H,et al.Relationship of hepatitis B or C virus prevalences,risk factors,and outcomes in renal transplant recipients:analysis of German data.Transplant Proc,2008,40:909-914.
  • 6Hoyer PF.‘Tie breaker'for HLA matching in pediatric renal transplant recipients?Am J Transplant,2008,8:1970-1971.
  • 7MeCune TR,Thacker LR 2nd,Blanton JW,et al.Sensitized patients require sharing of highly matched kidneys.Transplantation,2002,73:1891-1896.
  • 8Jirasiritham S,Sumethkul V,Mavichak V,et al.The role of anti-IL2 receptor in high-risk kidney transplant patients.Transplant Pree,2004,36:2110-2112.
  • 9Taber DJ,Weimert NA,Henderson F,et al.Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation.Transplant Proc,2008,40:3401-3407.
  • 10Sageshima J,Ciancio G,Chen L,et al.Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation.Biologics,2009,3:319-336.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部